申请人:Bayer Aktiengesellschaft
公开号:US05665740A1
公开(公告)日:1997-09-09
The present invention relates to the new compound rac-isopropyl 2-methoxyethyl 4-(2-chloro-3-cyano-phenyl)1,4 -dihydro-2,6-dimethylpyridine-3,5-dicarboxylate and its pure enantiomers, processes for their preparation and their use as medicaments, in particular for the treatment of cerebral and neuronal disorders, and a new intermediate for their preparation.
本发明涉及新化合物rac-异丙基2-甲氧基乙基4-(2-氯-3-氰基苯基)1,4-二氢-2,6-二甲基吡啶-3,5-二羧酸酯及其纯对映体,其制备过程以及它们作为药物的用途,特别是用于治疗脑和神经系统疾病,以及制备它们的新中间体。